110 related articles for article (PubMed ID: 10776795)
1. Lipopeptides as immunoadjuvants and immunostimulants in mucosal immunization.
Baier W; Masihi N; Huber M; Hoffmann P; Bessler WG
Immunobiology; 2000 Jan; 201(3-4):391-405. PubMed ID: 10776795
[TBL] [Abstract][Full Text] [Related]
2. Modulation of the Th1/Th2 bias by lipopeptide and saponin adjuvants in orally immunized mice.
Huber M; Baier W; Bessler WG; Heinevetter L
Immunobiology; 2002 Mar; 205(1):61-73. PubMed ID: 11999345
[TBL] [Abstract][Full Text] [Related]
3. Lipopeptide adjuvants in combination treatment.
Bessler WG; Mittenbühler K; Esche Uv; Huber M
Int Immunopharmacol; 2003 Aug; 3(8):1217-24. PubMed ID: 12860177
[TBL] [Abstract][Full Text] [Related]
4. Lipopeptides: adjuvanticity in conventional and genetic immunization.
Mittenbühler K; v d Esche U; Heinevetter L; Bessler WG; Huber M
FEMS Immunol Med Microbiol; 2003 Jul; 37(2-3):193-200. PubMed ID: 12832125
[TBL] [Abstract][Full Text] [Related]
5. Efficient mucosal delivery of the HIV-1 Tat protein using the synthetic lipopeptide MALP-2 as adjuvant.
Borsutzky S; Fiorelli V; Ebensen T; Tripiciano A; Rharbaoui F; Scoglio A; Link C; Nappi F; Morr M; Buttó S; Cafaro A; Mühlradt PF; Ensoli B; Guzmán CA
Eur J Immunol; 2003 Jun; 33(6):1548-56. PubMed ID: 12778472
[TBL] [Abstract][Full Text] [Related]
6. Lipopeptide-polyoxyethylene conjugates as mitogens and adjuvants.
Kleine B; Rapp W; Wiesmüller KH; Edinger M; Beck W; Metzger J; Ataulakhanov R; Jung G; Bessler WG
Immunobiology; 1994 Feb; 190(1-2):53-66. PubMed ID: 8082887
[TBL] [Abstract][Full Text] [Related]
7. Lipopeptide immunization without adjuvant induces potent and long-lasting B, T helper, and cytotoxic T lymphocyte responses against a malaria liver stage antigen in mice and chimpanzees.
BenMohamed L; Gras-Masse H; Tartar A; Daubersies P; Brahimi K; Bossus M; Thomas A; Druilhe P
Eur J Immunol; 1997 May; 27(5):1242-53. PubMed ID: 9174617
[TBL] [Abstract][Full Text] [Related]
8. Immunostimulation by bacterial components: I. Activation Of macrophages and enhancement of genetic immunization by the lipopeptide P3CSK4.
vd Esche U; Ayoub M; Pfannes SD; Müller MR; Huber M; Wiesmüller KH; Loop T; Humar M; Fischbach KF; Strünkelnberg M; Hoffmann P; Bessler WG; Mittenbühler K
Int J Immunopharmacol; 2000 Dec; 22(12):1093-102. PubMed ID: 11137616
[TBL] [Abstract][Full Text] [Related]
9. Drug specific antibodies: T-cell epitope-lipopeptide conjugates are potent adjuvants for small antigens in vivo and in vitro.
Mittenbühler K; Loleit M; Baier W; Fischer B; Sedelmeier E; Jung G; Winkelmann G; Jacobi C; Weckesser J; Erhard MH; Hofmann A; Bessler W; Hoffmann P
Int J Immunopharmacol; 1997 May; 19(5):277-87. PubMed ID: 9439766
[TBL] [Abstract][Full Text] [Related]
10. The Mycoplasma-derived lipopeptide MALP-2 is a potent mucosal adjuvant.
Rharbaoui F; Drabner B; Borsutzky S; Winckler U; Morr M; Ensoli B; Mühlradt PF; Guzmán CA
Eur J Immunol; 2002 Oct; 32(10):2857-65. PubMed ID: 12355438
[TBL] [Abstract][Full Text] [Related]
11. Bacterial lipopeptides constitute efficient novel immunogens and adjuvants in parenteral and oral immunization.
Bessler WG; Baier W; vd Esche U; Hoffmann P; Heinevetter L; Wiesmüller KH; Jung G
Behring Inst Mitt; 1997 Feb; (98):390-9. PubMed ID: 9382763
[TBL] [Abstract][Full Text] [Related]
12. Antibody responses to bee melittin (Api m 4) and hornet antigen 5 (Dol m 5) in mice treated with the dominant T-cell epitope peptides.
King TP; Lu G; Agosto H
J Allergy Clin Immunol; 1998 Mar; 101(3):397-403. PubMed ID: 9525458
[TBL] [Abstract][Full Text] [Related]
13. Intranasal lipopeptide primes lung-resident memory CD8+ T cells for long-term pulmonary protection against influenza.
Deliyannis G; Kedzierska K; Lau YF; Zeng W; Turner SJ; Jackson DC; Brown LE
Eur J Immunol; 2006 Mar; 36(3):770-8. PubMed ID: 16435281
[TBL] [Abstract][Full Text] [Related]
14. Intranasal Immunization Using Mannatide as a Novel Adjuvant for an Inactivated Influenza Vaccine and Its Adjuvant Effect Compared with MF59.
Ren ST; Zhang XM; Sun PF; Sun LJ; Guo X; Tian T; Zhang J; Guo QY; Li X; Guo LJ; Che J; Wang B; Zhang H
PLoS One; 2017; 12(1):e0169501. PubMed ID: 28052136
[TBL] [Abstract][Full Text] [Related]
15. Lipid-containing mimetics of natural triggers of innate immunity as CTL-inducing influenza vaccines.
Lau YF; Deliyannis G; Zeng W; Mansell A; Jackson DC; Brown LE
Int Immunol; 2006 Dec; 18(12):1801-13. PubMed ID: 17077175
[TBL] [Abstract][Full Text] [Related]
16. Synthetic lipopeptides as novel adjuvants.
Bessler WG; Jung G
Res Immunol; 1992 Jun; 143(5):548-53; discussion 579-80. PubMed ID: 1439136
[TBL] [Abstract][Full Text] [Related]
17. Intranasal immunization using biphasic lipid vesicles as delivery systems for OmlA bacterial protein antigen and CpG oligonucleotides adjuvant in a mouse model.
Alcón VL; Baca-Estrada M; Vega-López MA; Willson P; Babiuk LA; Kumar P; Foldvari M
J Pharm Pharmacol; 2005 Aug; 57(8):955-62. PubMed ID: 16102250
[TBL] [Abstract][Full Text] [Related]
18. Induction of an epitope-specific humoral immune response by lipopeptide-hapten conjugates: enhancement of the anti-melittin response by a synthetic T helper (Th)-cell epitope.
Hoffmann P; Loleit M; Mittenbühler K; Beck W; Wiesmüller KH; Jung G; Bessler WG
FEMS Immunol Med Microbiol; 1997 Apr; 17(4):225-34. PubMed ID: 9143880
[TBL] [Abstract][Full Text] [Related]
19. Protective mucosal immunity in aging is associated with functional CD4+ T cells in nasopharyngeal-associated lymphoreticular tissue.
Hagiwara Y; McGhee JR; Fujihashi K; Kobayashi R; Yoshino N; Kataoka K; Etani Y; Kweon MN; Tamura S; Kurata T; Takeda Y; Kiyono H; Fujihashi K
J Immunol; 2003 Feb; 170(4):1754-62. PubMed ID: 12574339
[TBL] [Abstract][Full Text] [Related]
20. Fibroblast-stimulating lipopeptide-1 as a potential mucosal adjuvant enhances mucosal and systemic immune responses to enterovirus 71 vaccine.
Lin YL; Cheng PY; Chin CL; Huang LM; Lin SY; Chiang BL
Vaccine; 2018 Jul; 36(29):4331-4338. PubMed ID: 29891349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
